CD82 anticorps (Middle Region)
-
- Antigène Voir toutes CD82 Anticorps
- CD82
-
Épitope
- Middle Region
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CD82 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- ELIRDYNSSR EDSLQDAWDY VQAQVKCCGW VSFYNWTDNA ELMNRPEVTY
- Homologie
- Human: 100%
- Attributs du produit
- This is a rabbit polyclonal antibody against CD82. It was validated on Western Blot.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of CD82
- Top Product
- Discover our top product CD82 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 242 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
- Antigène
- CD82
- Autre désignation
- CD82 (CD82 Produits)
- Synonymes
- anticorps AA682076, anticorps AL023070, anticorps C33, anticorps IA4, anticorps Kai1, anticorps Tspan27, anticorps 4F9, anticorps GR15, anticorps KAI1, anticorps R2, anticorps SAR2, anticorps ST6, anticorps TSPAN27, anticorps CD82 antigen, anticorps CD82 molecule, anticorps Cd82 molecule, anticorps Cd82, anticorps CD82
- Sujet
-
This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
Alias Symbols: 4F9, C33, GR15, IA4, KAI1, R2, SAR2, ST6, TSPAN27
Protein Interaction Partner: GGT1, CD81, CD53, UBC, LGALS3BP, AMFR, VANGL1, IGSF8, ITGA3, NUP88, PTGFRN, ITGB2, ITGA4, ERBB3, CD4, ERBB2, CD63, ITGA6, HLA-DRA, HLA-DMB, HLA-DMA, ITGB1, EGFR, HBEGF, CANX, LRP1, CD19, ITGAL, HLA-DOB, CD46, CD151, CD9, RUVBL1, POLR2A, KAT5, CTNNB1, RUVB
Protein Size: 242 - Poids moléculaire
- 27 kDa
- ID gène
- 3732
- NCBI Accession
- NM_001024844, NP_001020015
- UniProt
- P27701
- Pathways
- Signalisation p53
-